Cargando…
Burden of AML, 1990-2019: Estimates From the Global Burden of Disease Study
PURPOSE: AML accounts for 80% of acute leukemia in adults. While progress has been made in treating younger patients in the past 2 decades, there has been limited improvement for older patients until recently. This study examines the global and European Union (EU) 15+ trends in AML between 1990 and...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10681472/ https://www.ncbi.nlm.nih.gov/pubmed/37992271 http://dx.doi.org/10.1200/GO.23.00229 |
_version_ | 1785150808270045184 |
---|---|
author | Jani, Chinmay T. Ahmed, Alaaeldin Singh, Harpreet Mouchati, Christian Al Omari, Omar Bhatt, Padmanabh S. Sharma, Rajesh Farooq, Minaam Liu, Weitao Shalhoub, Joseph Marshall, Dominic Salciccioli, Justin D. Warner, Jeremy L. Lam, Prudence |
author_facet | Jani, Chinmay T. Ahmed, Alaaeldin Singh, Harpreet Mouchati, Christian Al Omari, Omar Bhatt, Padmanabh S. Sharma, Rajesh Farooq, Minaam Liu, Weitao Shalhoub, Joseph Marshall, Dominic Salciccioli, Justin D. Warner, Jeremy L. Lam, Prudence |
author_sort | Jani, Chinmay T. |
collection | PubMed |
description | PURPOSE: AML accounts for 80% of acute leukemia in adults. While progress has been made in treating younger patients in the past 2 decades, there has been limited improvement for older patients until recently. This study examines the global and European Union (EU) 15+ trends in AML between 1990 and 2019. METHODS: We extracted age-standardized incidence rates (ASIRs), age-standardized death rates (ASMRs), and disability-adjusted life years, stratified by sex from the Global Burden of Disease Study database, and mortality-to-incidence ratio (MIR) were computed. Trends were compared using Joinpoint regression. RESULTS: The findings show a global increase in AML incidence for both sexes from 1990 to 2019. In the EU15+ countries, most countries exhibited an increase in ASIR for both sexes. Joinpoint revealed that globally for male patients, ASIR steadily increased until 2010, remained stable until 2015 followed by a decline till 2019. Similar trends were observed in female patients. For ASMR, although there was an increase globally and in most EU15+ countries, there was a statistically significant decrease in mortality rates globally and in the majority of EU15+ countries in recent years. MIR improved in both sexes globally. On age stratification, AML burden was highest among older groups (55 years and older), while the lowest rates were observed in younger than 20 years. CONCLUSION: The findings from our study indicate a global rise in AML incidence and mortality in both sexes and decrease in MIR from 1990 to 2019 suggesting a better survival. However, on Joinpoint analysis, there is no change in MIR in women in the past decade and past 4 years in men indicating plateau in survival trends despite recent advances. |
format | Online Article Text |
id | pubmed-10681472 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Wolters Kluwer Health |
record_format | MEDLINE/PubMed |
spelling | pubmed-106814722023-11-22 Burden of AML, 1990-2019: Estimates From the Global Burden of Disease Study Jani, Chinmay T. Ahmed, Alaaeldin Singh, Harpreet Mouchati, Christian Al Omari, Omar Bhatt, Padmanabh S. Sharma, Rajesh Farooq, Minaam Liu, Weitao Shalhoub, Joseph Marshall, Dominic Salciccioli, Justin D. Warner, Jeremy L. Lam, Prudence JCO Glob Oncol ORIGINAL REPORTS PURPOSE: AML accounts for 80% of acute leukemia in adults. While progress has been made in treating younger patients in the past 2 decades, there has been limited improvement for older patients until recently. This study examines the global and European Union (EU) 15+ trends in AML between 1990 and 2019. METHODS: We extracted age-standardized incidence rates (ASIRs), age-standardized death rates (ASMRs), and disability-adjusted life years, stratified by sex from the Global Burden of Disease Study database, and mortality-to-incidence ratio (MIR) were computed. Trends were compared using Joinpoint regression. RESULTS: The findings show a global increase in AML incidence for both sexes from 1990 to 2019. In the EU15+ countries, most countries exhibited an increase in ASIR for both sexes. Joinpoint revealed that globally for male patients, ASIR steadily increased until 2010, remained stable until 2015 followed by a decline till 2019. Similar trends were observed in female patients. For ASMR, although there was an increase globally and in most EU15+ countries, there was a statistically significant decrease in mortality rates globally and in the majority of EU15+ countries in recent years. MIR improved in both sexes globally. On age stratification, AML burden was highest among older groups (55 years and older), while the lowest rates were observed in younger than 20 years. CONCLUSION: The findings from our study indicate a global rise in AML incidence and mortality in both sexes and decrease in MIR from 1990 to 2019 suggesting a better survival. However, on Joinpoint analysis, there is no change in MIR in women in the past decade and past 4 years in men indicating plateau in survival trends despite recent advances. Wolters Kluwer Health 2023-11-22 /pmc/articles/PMC10681472/ /pubmed/37992271 http://dx.doi.org/10.1200/GO.23.00229 Text en © 2023 by American Society of Clinical Oncology https://creativecommons.org/licenses/by/4.0/Licensed under the Creative Commons Attribution 4.0 License: http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) |
spellingShingle | ORIGINAL REPORTS Jani, Chinmay T. Ahmed, Alaaeldin Singh, Harpreet Mouchati, Christian Al Omari, Omar Bhatt, Padmanabh S. Sharma, Rajesh Farooq, Minaam Liu, Weitao Shalhoub, Joseph Marshall, Dominic Salciccioli, Justin D. Warner, Jeremy L. Lam, Prudence Burden of AML, 1990-2019: Estimates From the Global Burden of Disease Study |
title | Burden of AML, 1990-2019: Estimates From the Global Burden of Disease Study |
title_full | Burden of AML, 1990-2019: Estimates From the Global Burden of Disease Study |
title_fullStr | Burden of AML, 1990-2019: Estimates From the Global Burden of Disease Study |
title_full_unstemmed | Burden of AML, 1990-2019: Estimates From the Global Burden of Disease Study |
title_short | Burden of AML, 1990-2019: Estimates From the Global Burden of Disease Study |
title_sort | burden of aml, 1990-2019: estimates from the global burden of disease study |
topic | ORIGINAL REPORTS |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10681472/ https://www.ncbi.nlm.nih.gov/pubmed/37992271 http://dx.doi.org/10.1200/GO.23.00229 |
work_keys_str_mv | AT janichinmayt burdenofaml19902019estimatesfromtheglobalburdenofdiseasestudy AT ahmedalaaeldin burdenofaml19902019estimatesfromtheglobalburdenofdiseasestudy AT singhharpreet burdenofaml19902019estimatesfromtheglobalburdenofdiseasestudy AT mouchatichristian burdenofaml19902019estimatesfromtheglobalburdenofdiseasestudy AT alomariomar burdenofaml19902019estimatesfromtheglobalburdenofdiseasestudy AT bhattpadmanabhs burdenofaml19902019estimatesfromtheglobalburdenofdiseasestudy AT sharmarajesh burdenofaml19902019estimatesfromtheglobalburdenofdiseasestudy AT farooqminaam burdenofaml19902019estimatesfromtheglobalburdenofdiseasestudy AT liuweitao burdenofaml19902019estimatesfromtheglobalburdenofdiseasestudy AT shalhoubjoseph burdenofaml19902019estimatesfromtheglobalburdenofdiseasestudy AT marshalldominic burdenofaml19902019estimatesfromtheglobalburdenofdiseasestudy AT salcicciolijustind burdenofaml19902019estimatesfromtheglobalburdenofdiseasestudy AT warnerjeremyl burdenofaml19902019estimatesfromtheglobalburdenofdiseasestudy AT lamprudence burdenofaml19902019estimatesfromtheglobalburdenofdiseasestudy |